ES2137878B1 - PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. - Google Patents
PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE.Info
- Publication number
- ES2137878B1 ES2137878B1 ES9702496A ES9702496A ES2137878B1 ES 2137878 B1 ES2137878 B1 ES 2137878B1 ES 9702496 A ES9702496 A ES 9702496A ES 9702496 A ES9702496 A ES 9702496A ES 2137878 B1 ES2137878 B1 ES 2137878B1
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- obtaining
- therapeutic use
- plasma
- human plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Procedimiento de obtención de un plasma humano atenuado de virus para uso terapéutico. El procedimiento se caracteriza porque la mezcla del plasma tratado es estabilizado y protegida contra la degradación, siendo los restos de los reactivos empleados en el método de inactivación eliminados por adsorción con una resina selectiva, complementándose con una concentración por ultrafiltración hasta obtener un plasma cuya composición proteica es equivalente al plasma fresco congelado y es apto para su transfusión.Procedure for obtaining an attenuated virus human plasma for therapeutic use. The procedure is characterized in that the mixture of the treated plasma is stabilized and protected against degradation, the remains of the reagents used in the inactivation method being removed by adsorption with a selective resin, complemented by concentration by ultrafiltration until obtaining a plasma whose composition Protein is equivalent to fresh frozen plasma and is suitable for transfusion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9702496A ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9702496A ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2137878A1 ES2137878A1 (en) | 1999-12-16 |
ES2137878B1 true ES2137878B1 (en) | 2000-10-01 |
Family
ID=8301352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9702496A Expired - Fee Related ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2137878B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4142908C2 (en) * | 1991-12-24 | 1994-02-10 | Octapharma Ag Glarus | Method for producing a virus-inactivated prothrombin complex concentrate (PPSB) |
DE4337573C1 (en) * | 1993-11-04 | 1995-05-18 | Octapharma Ag | Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods |
-
1997
- 1997-12-01 ES ES9702496A patent/ES2137878B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2137878A1 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26724A1 (en) | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUSES | |
DE69835279D1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS USING CATIONIC PEPTIDES ALONE OR IN COMBINATION WITH ANTIBIOTICS | |
ID29393A (en) | COMPOSITION OF CANCER TREATMENT AND METHOD OF USING NATURAL PLANT ESENSIL OILS | |
AR013670A1 (en) | DEVICE FOR THE TREATMENT OF VARICOSE VEINS | |
BR0214772A (en) | systems and methods for treating patients with processed liposuction cells | |
ATE106740T1 (en) | PREPARATION OF T-CELLS AND T-CELL MEMBRANES USABLE FOR PREVENTING AND TREATMENT OF AUTOIMMUNE DISEASES. | |
TR200102308T2 (en) | Artificial peptides with surface activity and their use in the preparation of artificial surfactants | |
NO951761L (en) | Stable preparation for the treatment of blood coagulation disorders | |
BR0113006A (en) | Method for treating type II glycogen storage disease in an individual and its use | |
ATE260041T1 (en) | METHOD FOR THE GERMINATION-INHIBITING TREATMENT OF TUBERS AND ONIONS WITH EUGENOL AND/OR ISOEUGENOL | |
RU94022754A (en) | Method for preventing and treating ischemia attacks and reperfusion-induced injuries influenced by the attacks | |
DE69116380D1 (en) | PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME | |
DK1201137T3 (en) | Cysteine / glycine-rich peptides | |
FI961536A0 (en) | Procedure for inactivating viruses in the presence of polyalkylene glycol and thus obtained pharmaceutical preparation | |
DK1001775T3 (en) | Medication containing yohimbine and arginine intended to treat erectile dysfunction | |
DK1648496T3 (en) | A method of stabilizing a cryoprecipitate of plasmatic proteins intended to be subjected to a heat treatment for virus inactivation | |
EP0214017A3 (en) | Use of n,n,-dimethylbiguanid p-chorophenoxyacetate in the treatment of neuropathies and nerval degeneration | |
DE50108409D1 (en) | TREATMENT OF SURFACES FOR THE TEMPORARY IMPROVEMENT OF DIRT-RELATED BEHAVIOR | |
ES2113910T3 (en) | PROCEDURE FOR THE PREPARATION OF A TROMBINE CONCENTRATE INSURED AGAINST VIRUSES. | |
ES2137878B1 (en) | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. | |
DE69632629D1 (en) | THROMBIN COMPOSITION | |
DE60103658D1 (en) | EX-VIVO CLL CELLS TREATED UNDER OXIDATIVE STRESS FOR TREATING CHRONIC LYMPHOCYTIC LEAUCEMY (CLL) | |
ATE544453T1 (en) | COMBINATION THERAPIES WITH L-FMAU FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS | |
DE69927815D1 (en) | INOSITOLPHOSPHOGLYCAN AND RIBOSE FOR THE TREATMENT OF ISCHEMIC REPERFUSION DAMAGE | |
EA200100223A3 (en) | Water dispersed ivermectin dosage form for curing ecto- endoparasitic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19991216 Kind code of ref document: A1 Effective date: 19991216 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180326 |